EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Emerging Role of MicroRNAs in Oral Cancer: From Pathogenesis to Targeted Therapy

Mehmet Bugrahan Duz, Seda Salman Yilmaz, Sahra Acir, Mustafa Ozen

Onco · 17.04.2026 · 6 (2) · 20

DOI: 10.3390/onco6020020 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Onco, online erschienen am 17.04.2026. Verfasst von Mehmet Bugrahan Duz und 3 weiteren Autor:innen. Die Arbeit nennt 222 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Oral cancer remains a major global health problem with high morbidity and mortality rates, and despite advances in therapeutic approaches, challenges persist in early diagnosis and effective disease management. MicroRNAs (miRNAs) are endogenous, small non-coding RNAs that regulate gene expression at the post-transcriptional level and play fundamental roles in maintaining cellular homeostasis, as well as in the initiation and progression of multiple malignancies, including oral cancer. Dysregulation of miRNAs contributes to oral carcinogenesis by modulating key cellular processes such as cell proliferation, apoptosis, invasion, metastasis, and angiogenesis. Altered miRNA expression profiles have been consistently identified in oral cancer tissues and body fluids, including saliva and blood, supporting their potential utility as reliable biomarkers for early detection, prognosis, and disease monitoring. Circulating miRNAs, in particular, represent a promising non-invasive diagnostic tool for assessing disease progression and therapeutic response. Moreover, miRNAs are actively involved in regulating sensitivity and resistance to chemotherapy and radiotherapy, with specific miRNAs either enhancing treatment efficacy or promoting therapeutic resistance. This review aims to highlight the critical role of miRNAs in oral cancer pathogenesis, diagnosis, prognosis, and treatment, exploring their potential as biomarkers and therapeutic targets to improve early detection, patient outcomes, and personalized treatment strategies.

Zitieren

APA

Duz, M. B., Yilmaz, S. S., Acir, S., & Ozen, M. (2026). The Emerging Role of MicroRNAs in Oral Cancer: From Pathogenesis to Targeted Therapy. Onco, 6(2), 20. https://doi.org/10.3390/onco6020020

Vancouver

Duz MB, Yilmaz SS, Acir S, Ozen M. The Emerging Role of MicroRNAs in Oral Cancer: From Pathogenesis to Targeted Therapy. Onco. 2026;6(2):20. doi:10.3390/onco6020020

BibTeX
@article{Duz2026,
  author = {Duz, Mehmet Bugrahan and Yilmaz, Seda Salman and Acir, Sahra and Ozen, Mustafa},
  title = {The Emerging Role of MicroRNAs in Oral Cancer: From Pathogenesis to Targeted Therapy},
  journal = {Onco},
  year = {2026},
  volume = {6},
  number = {2},
  pages = {20},
  doi = {10.3390/onco6020020}
}
Kostenlos starten →